Maze Therapeutics, Inc. (MAZE) Insider Trading

Name: Maze Therapeutics, Inc. (MAZE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Coloma Jason V (Chief Executive Officer): Sale of 2,593 shares, $70.1K.

Get alerted when insiders trade MAZE

Email address

Loading company data...

Beta

Loading company details...

Beta